Healthcare & Medical
Category / Healthcare & Medical
TOKYO: OMRON Healthcare releases new Women's Heart Health Factbook highlighting global hypertension care gap and life-stage risk factors ...
HONG KONG: HONG KONG, Feb 25, 2026 - (ACN Newswire) – Everest Medicines shareholders passed all proposed resolutions at an extraordinary general meeting (the “EGM”) held virtually on February 24, 2026, the ...
BOSTON, MA,: Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus ...
BOSTON, MA,: BOSTON, MA, Feb 17, 2026 - (ACN Newswire) - Bioxytran, Inc. (OTCMKTS: BIXT) (“Bioxytran” or the “Company”), a biotechnology company developing galectin-targeting carbohydrate technologies with ...
Boston: BOSTON, Feb 11, 2026 - (ACN Newswire) - Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-o ...
HONG KONG: HONG KONG, Feb 6, 2026 - (ACN Newswire) – Everest Medicines today announced that China's National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) f ...
TOKYO: Expanding production capacity by introducing automated equipment reduces manufacturing costs and shortens delivery times ...
HONG KONG: Shanghai, January 5, 2026 - (ACN Newswire) – Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical develop ...
TOKYO: Cloud-based AI application for colorectal cancer prevention: Enhancing detection of clinically significant lesions without compromising safety and workflow efficiency ...
NEEDHAM, MA,: NEEDHAM, MA, Feb 2, 2026 - (ACN Newswire) - Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glyco ...
NEEDHAM, MASS.,: Company reiterates focus on advancing ProLectin-M under an active FDA IND and progressing oxygen-transport programs for stroke and neurodegenerative disease ...
TOKYO: TANAKA will showcase platinum- and other precious metal-based materials, backed by 140 years of expertise, advanced processing technologies, and a stable global supply system ...
SINGAPORE: SINGAPORE, January 7, 2026 - (ACN Newswire) - Leading regional private healthcare provider group Fullerton Health (“Fullerton Health” or the “Group”) said today it has successfully acquired on ...
SINGAPORE: SINGAPORE, Dec 24, 2025 - (ACN Newswire) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, an ...
HONG KONG: HONG KONG, December 15, 2025 - (ACN Newswire) – Everest Medicines (HKEX: 1952.HK) today unveiled its 2030 strategy. Following the announcement, the Company’s shares strengthened during the trading ...
HONG KONG: HONG KONG, Oct 14, 2025 - (ACN Newswire) – Everest Medicines today announced that the first patient has been enrolled in a global multi-center Phase I clinical trial of its Tumor-Associated Antigen ...
HONG KONG: HONG KONG, Oct 30, 2025 - (ACN Newswire) – Everest Medicines (HKEX:1952.HK) today announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Bio ...
HONG KONG:
HONG KONG, December 12, 2025 - (ACN Newswire) – Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd (“Everest Medicines China”), h ...
PETALING JAYA, Malaysia,: Partnership drives clinical research, hands-on student training, and access to cutting-edge medical technologies
...
